|Articles|October 1, 2019
- Pharmaceutical Executive-10-01-2019
- Volume 39
- Issue 10
Pharmaceutical Executive, October 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Tech Tour for the C-Suite: Pharma’s Digital Futureabout 6 years ago
It Starts with a Scribbleabout 6 years ago
Olivier Laureau, Servier: Free to Grow, Innovateabout 6 years ago
Corey McCann: A PDT Pioneerabout 6 years ago
Data Shape-Up: Striving to Standardizeabout 6 years ago
Policy Sync-Up: The Drug Importation Conundrumabout 6 years ago
Validating Value Data: AI and Outcomesabout 6 years ago
Underlying Platform: Data Unleashedabout 6 years ago
Surfing the Wave: The Patient-Data Puzzleabout 6 years ago
Where Does Europe’s Drug Industry Go from Here?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Relation Therapeutics Forms $1.7 Billion Multi-Program Collaboration with Novartis Advancing Therapeutics for Atopic Diseases
2
Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists
3
Eli Lilly’s Jaypirca Achieves Primary Endpoint in Head-to-Head Phase III Study Against Imbruvica Treating CLL/SLL
4
Carvykti Displays Sustained Remissions in Early Use for Relapsed or Refractory Multiple Myeloma
5
